LP
BLUE

LMR Partners’s bluebird bio BLUE Stock Holding History

LMR Partners’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-4,016
Closed -$1.57M – 1131
2021
Q1 		$1.57M Buy
+4,016
New +$1.98M 0.04% 383
2020
Q2 		– Sell
-488
Closed -$297K – 599
2020
Q1 		$297K Sell
488
-732
-60% -$713K 0.01% 204
2019
Q4 		$1.39K Hold
1,220
– – ﹤0.01% 171
2019
Q3 		$1.45M Hold
1,220
– – 0.07% 130
2019
Q2 		$2.01M Sell
1,220
-324
-21% -$561K 0.07% 130
2019
Q1 		$3.15M Buy
+1,544
New +$2.72M 0.16% 94
2018
Q4 		– Sell
-244
Closed -$462K – 345
2018
Q3 		$462K Sell
244
-4,642
-95% -$9.59M 0.03% 198
2018
Q2 		$9.93M Buy
+4,886
New +$11.1M 0.51% 34
2017
Q3 		– Sell
-2,758
Closed -$3.75M – 342
2017
Q2 		$3.75M Buy
+2,758
New +$3.33M 0.24% 76

Other funds holding BLUE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

LMR Partners's BLUE Position: Q2 2021 in Review

LMR Partners sold out of bluebird bio (BLUE) in Q2 2021, closing a stake of 4,016 shares — an estimated $1.57M sold.

LMR Partners first reported a position in BLUE in Q2 2017 and held it in 9 quarters. The position peaked at $9.93M in Q2 2018. 232 funds tracked by Wall St. Rank hold BLUE as of Q2 2021.

  • LMR Partners reported no remaining bluebird bio position as of Q2 2021 after selling out during the quarter.
  • LMR Partners sold 4,016 bluebird bio shares in Q2 2021, an estimated $1.57M.
  • LMR Partners first reported a position in bluebird bio in Q2 2017 and held it in 9 quarters.
  • LMR Partners's bluebird bio position peaked at $9.93M in Q2 2018.
  • 232 funds tracked by Wall St. Rank held bluebird bio as of Q2 2021.

Based on LMR Partners's 13F filing for Q2 2021, filed 16 Aug 2021.